Accelerate Gene Therapy R&D with the Benchling R&D Cloud
This solution brief outlines the critical considerations for a modern informatics platform to efficiently accelerate gene therapy R&D and highlights how Benchling helps leading gene therapy companies.

Overview

Gene therapy technologies such as viral vectors, non-viral delivery systems, and CRISPR are giving R&D teams new ways to innovate and discover new cures to severe genetic disorders. Modern gene therapy requires a strong digital foundation to comprehensively characterize gene therapy candidates, maintain traceability across sequences, samples, and processes, and generate actionable insights to bring the best products into the clinic. This solution brief outlines:

  • The need for a modern purpose-built informatics solution specifically for gene therapy R&D

  • Introduces Benchling’s solution for gene therapy research and development

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image